1.
TO ASSESS THE EFFECTIVENESS OF FIRST-LINE XELOX COMBINED WITH BEVACIZUMAB IN PATIENTS WITH STAGE IV COLORECTAL CANCER TREATED AT NGHE AN ONCOLOGY HOSPITAL. YHCĐ. 2026;67(Số CĐ12- Bệnh viện Ung bướu Nghệ An). doi:10.52163/yhc.v67iCD12.6141